BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30525881)

  • 1. [Primary immunodeficiencies and haemato-oncology].
    Müller J; Kovács G
    Orv Hetil; 2018 Dec; 159(49):2073-2078. PubMed ID: 30525881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basics of primary immunodeficiencies].
    Hernández-Martínez C; Espinosa-Rosales F; Espinosa-Padilla SE; Hernández-Martínez AR; Blancas-Galicia L
    Rev Alerg Mex; 2016; 63(2):180-9. PubMed ID: 27174761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary and secondary immunodeficiencies].
    Cantoni N; Recher M
    Ther Umsch; 2014 Jan; 71(1):31-43. PubMed ID: 24394207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary immunodeficiencies and hematological malignancies].
    Kanegane H; Hoshino A; Takagi M
    Rinsho Ketsueki; 2018; 59(11):2459-2467. PubMed ID: 30531144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematological Malignancies Associated With Primary Immunodeficiency Disorders.
    Duan L; Grunebaum E
    Clin Immunol; 2018 Sep; 194():46-59. PubMed ID: 29966714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7th International Immunoglobulin Conference: Immunodeficiencies.
    Schmidt RE; Ochs HD
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):3-4. PubMed ID: 25546741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes at the Crossroad of Primary Immunodeficiencies and Cancer.
    Derpoorter C; Bordon V; Laureys G; Haerynck F; Lammens T
    Front Immunol; 2018; 9():2544. PubMed ID: 30443258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
    Ballow M; Sánchez-Ramón S; Walter JE
    Front Immunol; 2022; 13():928062. PubMed ID: 35924244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.
    Gernez Y; Baker MG; Maglione PJ
    Transfusion; 2018 Dec; 58 Suppl 3(Suppl 3):3056-3064. PubMed ID: 30536429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rheumatological manifestations in primary immunodeficiency diseases].
    Szabó MZ
    Orv Hetil; 2018 Jun; 159(23):919-928. PubMed ID: 29860881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012).
    Mellouli F; Mustapha IB; Khaled MB; Besbes H; Ouederni M; Mekki N; Ali MB; Larguèche B; Hachicha M; Sfar T; Gueddiche N; Barsaoui S; Sammoud A; Boussetta K; Becher SB; Meherzi A; Guandoura N; Boughammoura L; Harbi A; Amri F; Bayoudh F; Jaballah NB; Tebib N; Bouaziz A; Mahfoudh A; Aloulou H; Mansour LB; Chabchoub I; Boussoffara R; Chemli J; Bouguila J; Hassayoun S; Hammami S; Habboul Z; Hamzaoui A; Ammar J; Barbouche MR; Bejaoui M
    J Clin Immunol; 2015 Nov; 35(8):745-53. PubMed ID: 26464197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Effectiveness of the 6 Warning Signs of the European Society for Immunodeficiencies for Primary Immunodeficiencies in Older Adults.
    Yildiz E; Çölkesen F; Evcen R; Sadi Aykan F; Kılınç M; Arslan S
    Int Arch Allergy Immunol; 2024; 185(4):402-410. PubMed ID: 38219730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.
    Bousfiha A; Jeddane L; Al-Herz W; Ailal F; Casanova JL; Chatila T; Conley ME; Cunningham-Rundles C; Etzioni A; Franco JL; Gaspar HB; Holland SM; Klein C; Nonoyama S; Ochs HD; Oksenhendler E; Picard C; Puck JM; Sullivan KE; Tang ML
    J Clin Immunol; 2015 Nov; 35(8):727-38. PubMed ID: 26445875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders.
    Hauck F; Voss R; Urban C; Seidel MG
    J Allergy Clin Immunol; 2018 Jan; 141(1):59-68.e4. PubMed ID: 28669558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The forefront of primary immunodeficiencies].
    Hoshino A
    Rinsho Ketsueki; 2018; 59(10):2195-2203. PubMed ID: 30305526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA repair: the link between primary immunodeficiency and cancer.
    de Miranda NF; Björkman A; Pan-Hammarström Q
    Ann N Y Acad Sci; 2011 Dec; 1246():50-63. PubMed ID: 22236430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immunodeficiencies: "new" disease in an old country.
    Lee PP; Lau YL
    Cell Mol Immunol; 2009 Dec; 6(6):397-406. PubMed ID: 20003815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune and Inflammatory Manifestations in 247 Patients with Primary Immunodeficiency-a Report from the Slovenian National Registry.
    Blazina Š; Markelj G; Jeverica AK; Toplak N; Bratanič N; Jazbec J; Kopač P; Debeljak M; Ihan A; Avčin T
    J Clin Immunol; 2016 Nov; 36(8):764-773. PubMed ID: 27582173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral manifestations in patients with primary immunodeficiencies].
    Szegedi M; Erdős M; Tar I
    Orv Hetil; 2018 Dec; 159(49):2079-2086. PubMed ID: 30525885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of cancer in patients with primary immunodeficiencies.
    Salavoura K; Kolialexi A; Tsangaris G; Mavrou A
    Anticancer Res; 2008; 28(2B):1263-9. PubMed ID: 18505064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.